Literature DB >> 22704685

Dissemination of antibiotic-resistant enterococci within the ward environment: the role of airborne bacteria and the risk posed by unrecognized carriers.

Monika Muzslay1, Ginny Moore, Jane F Turton, A Peter Wilson.   

Abstract

BACKGROUND: Colonized or infected patients pose a significant risk to noncolonized patients occupying the same room. The aim of this study was to investigate how far Enterococcus spp can spread from isolated and nonisolated patients.
METHODS: Conventional microbiological methods were used to recover enterococci from the air and from 62 high-contact sites located within the near-patient and wider ward environment. Samples were collected twice weekly for 17 weeks. The similarity between isolates was determined via pulsed-field gel electrophoresis.
RESULTS: Vancomycin-susceptible enterococci (VSE) were recovered from 352 of 2,046 environmental surfaces (17.2%) and from 27 of 66 air samples (40.9%). During study week 14, VSE was recovered from 75 of the 124 surfaces sampled, representing 21.3% of all VSE-positive sites. A gentamicin-resistant VS Enterococcus faecium clone was recovered in high numbers from the air (>100 cfu/m(3)) and from surfaces throughout a 4-bed bay. The same clone was recovered from an adjacent isolation room as well. A total of 55 surfaces were contaminated with vancomycin-resistant enterococci (VRE). The environment of 2 isolated patients accounted for 85% of contaminated sites. Neither patient was known to be VRE-positive.
CONCLUSIONS: Unrecognized colonization and/or the aerosolization of enterococci together with inadequate cleaning can lead to heavy, widespread, and persistent environmental contamination. All pose a significant risk for acquisition of antibiotic-resistant enterococci.
Copyright © 2013 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22704685     DOI: 10.1016/j.ajic.2012.01.031

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  6 in total

Review 1.  Best practice in healthcare environment decontamination.

Authors:  H Siani; J-Y Maillard
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-07-26       Impact factor: 3.267

2.  The strength of coughing may forecast the likelihood of spread of multi-drug resistant microorganisms from the respiratory tract of colonized patients.

Authors:  Magda Diab-Elschahawi; Luigi Segagni Lusignani; Peter Starzengruber; Dieter Mitteregger; Andrea Wagner; Ojan Assadian; Elisabeth Presterl
Journal:  Antimicrob Resist Infect Control       Date:  2014-12-12       Impact factor: 4.887

Review 3.  Generic aspects of the airborne spread of human pathogens indoors and emerging air decontamination technologies.

Authors:  M Khalid Ijaz; Bahram Zargar; Kathryn E Wright; Joseph R Rubino; Syed A Sattar
Journal:  Am J Infect Control       Date:  2016-09-02       Impact factor: 2.918

4.  Occurrence of airborne vancomycin- and gentamicin-resistant bacteria in various hospital wards in Isfahan, Iran.

Authors:  Seyed Hamed Mirhoseini; Mahnaz Nikaeen; Hossein Khanahmad; Akbar Hassanzadeh
Journal:  Adv Biomed Res       Date:  2016-08-30

5.  Environmental remodeling of human gut microbiota and antibiotic resistome in livestock farms.

Authors:  Jian Sun; Xiao-Ping Liao; Alaric W D'Souza; Manish Boolchandani; Sheng-Hui Li; Ke Cheng; José Luis Martínez; Liang Li; You-Jun Feng; Liang-Xing Fang; Ting Huang; Jing Xia; Yang Yu; Yu-Feng Zhou; Yong-Xue Sun; Xian-Bo Deng; Zhen-Ling Zeng; Hong-Xia Jiang; Bing-Hu Fang; You-Zhi Tang; Xin-Lei Lian; Rong-Min Zhang; Zhi-Wei Fang; Qiu-Long Yan; Gautam Dantas; Ya-Hong Liu
Journal:  Nat Commun       Date:  2020-03-18       Impact factor: 14.919

6.  Inactivation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by gaseous ozone treatment.

Authors:  H Yano; R Nakano; Y Suzuki; A Nakano; K Kasahara; H Hosoi
Journal:  J Hosp Infect       Date:  2020-10-10       Impact factor: 3.926

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.